Shonukan, O.; Dantzig, A.; Kloeker-Rhoades, S.; Garcia-Ribas, I. Development of LY2334737, an Oral Gemcitabine Prodrug for Continuous Administration. Perspectives for the Therapy of Mature T-Cell and NK-Cell Lymphomas. Hematol Meeting Rep 2009, 3.